Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
about
Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancerHonokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.
P2860
Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Combination Approach of YSA Pe ...... the Treatment of Lung Cancer.
@en
type
label
Combination Approach of YSA Pe ...... the Treatment of Lung Cancer.
@en
prefLabel
Combination Approach of YSA Pe ...... the Treatment of Lung Cancer.
@en
P2093
P2860
P1476
Combination Approach of YSA Pe ...... the Treatment of Lung Cancer.
@en
P2093
Ketan Patel
Mandip Singh
Nusrat Chowdhury
Ravi Doddapaneni
Vasanthakumar Sekar
P2860
P304
P356
10.1021/ACS.MOLPHARMACEUT.6B00187
P407
P577
2016-04-12T00:00:00Z